Krystal Biotech says it's on schedule for filing for license with FDA
May 09, 2022 at 16:48 PM EDT
"Our primary objective in 2022 is to prepare for the potential approval and launch of B-VEC in the U.S.," the company's CEO said.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |